MPD: List measures where strain NOD/ShiLtJ is an outlier

List measures where NOD/ShiLtJ is an outlier

Click on pulldowns below to see NOD/ShiLtJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year

Auwerx2:95	Auwerx2	monitoring system	(none)	horizontal activity (beam breaks) during day, basal activity test, for 48h [n/h] horiz_act_day 114623 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:99	Auwerx2	monitoring system	(none)	horizontal activity (beam breaks) at night, basal activity test, for 48h [n/h] horiz_act_night 114627 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:163	Auwerx2	lipid profile	(none)	plasma triglyceride amount [mmol/L] triglyc 114691 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:165	Auwerx2	lipid profile	(none)	plasma free fatty acids amount [mmol/L] fatty_acids 114693 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Berndt2:21	Berndt2	plethysmography	methacholine	expiratory phase [s] expiratory 35121 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:28	Berndt2	plethysmography	methacholine	respiratory cycle [s] tot_respi 35128 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Bopp1:4	Bopp1	health assessment	Plasmodium berghei	percentage of parasites in brain relative to all organs tested [%] luciferase_brain 36404	inbred	28	both	8-12wks	N=2	2010

CGDpheno1:7	CGDpheno1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 31807	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:27	CGDpheno1	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 31827	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno3:5	CGDpheno3	complete blood count	(none)	red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 43905	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:7	CGDpheno3	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 43907	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:8	CGDpheno3	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 43908	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:13	CGDpheno3	complete blood count	(none)	reticulocyte differential (Retic; percentage of total RBC) [%] pctRetic 43913	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:15	CGDpheno3	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 43915	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:16	CGDpheno3	complete blood count	(none)	mean RBC corpuscular hemoglobin conent (MCH) [pg] MCH 43916	CC diallel w/par	62	both	7wks	N=5	2012

Chesler2:19	Chesler2	complete blood count	(none)	red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 43421	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:22	Chesler2	complete blood count	(none)	mean RBC corpuscular hemoglobin (MCH) [pg] MCH 43424	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:23	Chesler2	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43425	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:25	Chesler2	complete blood count	(none)	hematocrit (HCT) [%] hematocrit 43427	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:29	Chesler2	colony observation	(none)	parental age at first litter [d] age_first_litter 43442	CC diallel w/par	62	both	4wks	N=8	2011

Chesler3:21	Chesler3	complete blood count	(none)	red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 43521	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:24	Chesler3	complete blood count	(none)	mean RBC corpuscular hemoglobin (MCH) [pg] MCH 43524	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:25	Chesler3	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43525	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:27	Chesler3	complete blood count	(none)	hematocrit (HCT) [%] hematocrit 43527	CC pre w/par	200	both	7-15wks	N=1	2011

Chesler3:41	Chesler3	colony observation	(none)	number of mice born in first litter [n] litter_size 43541	CC pre w/par	312	both	4wks	N=2	2011

Chesler4:7	Chesler4	light-dark box	(none)	distance traveled in light compartment, 20 min test [cm] LD_distance_light 47007	DO population w/par	9	both	12-16wks	N=8	2013

Collins1:6	Collins1	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] NEUT_pct 45106	CC pre w/par	138	m	10-14wks	N=1	2012

Cowell1:5	Cowell1	health assessment	Staphylococcus aureus	percent survival, max time 104h [%] pct_survival 49005	inbred	13	f	8wks	N=11	2012

Crabbe3:58	Crabbe3	rotarod	(none)	average latency to fall, accelerating rotarod, 20 rpm/min (ARR2), post-injection saline control minus pre-injection saline control (SALPOST - SALBASE) [s] ARR2_chg_20rpm_saline 15858	inbred	21	both	9-17wks	N=9	2003

Crowley1:25	Crowley1	open field test	haloperidol	center occupancy, percentage of total time [%] pct_center 39425 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

CSNA02:1	CSNA02	open field test	(none)	distance traveled, 40 min test [cm] locomotor 62201 day 1 day 2 day 2 minus day 1	inbred	10	both	10wks	N=8	2018

CSNA02:16	CSNA02	operant conditioning chamber	(none)	latency to receive Boost divided by total number of trials [s] reward_latency 62216 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA03:14	CSNA03	open field test	(none)	percentage of total distance traveled in center, 60 min test (OFT), CC [%] pct_dist_center_OFT_cc 90014	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:16	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), founders dist_slope_OFT_in 90016	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:17	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), CC dist_slope_OFT_cc 90017	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:18	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), DO dist_slope_OFT_do 90018	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:31	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:110	CSNA03	open field test	(none)	percentage of total time spent in center, 60 min test (OFT), CC [%] pct_center_time_OFT_cc 90110	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:113	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC [%] pct_dist_perimeter_corners_OFT_cc 90113	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:116	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter, 60 min test (OFT), CC [%] pct_dist_perimeter_OFT_cc 90116	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:124	CSNA03	open field test	(none)	time in center, 60 min test (OFT), founders [s] center_time_OFT_in 90124	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:125	CSNA03	open field test	(none)	time in center, 60 min test (OFT), CC [s] center_time_OFT_cc 90125	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:128	CSNA03	open field test	(none)	distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:343	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:370	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:397	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:406	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:424	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:506	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:661	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:663	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal	CC w/par	18	both		N=4	2021

DiPetrillo2:2	DiPetrillo2	urinalysis	(none)	creatinine (urine CREA) [mg/dL] CREA 46102	CC pre w/par	163	m	10wks	N=2	2012

Donahue1:13	Donahue1	DXA	(none)	inner canthal distance [mm] inner_canthal 11522	inbred w/CC7	29	both	15-16wks	N=9	2002

GMC01:41	GMC01	open field test	(none)	distance traveled in center of arena, 20 min test [cm] center_distance 55041	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC01:46	GMC01	open field test	(none)	number of entries in center of arena, 20 min test [n] center_entries 55046	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC01:61	GMC01	open field test	(none)	center time, successive 5 min intervals [%] center_time 55061 1st 5min 2nd 5min 3rd 5min 4th 5min	inbred w/CC8	8	both	8-9wks	N=17	2018

GMC09:51	GMC09	monitoring system	(none)	mean total beam breaks on X-axis, 21 h test, 15 min bins [n] breaks_X_mean 55851	inbred w/CC8	8	both	12-13wks	N=17	2018

GMC09:52	GMC09	monitoring system	(none)	mean ambulatory movement on X-axis, 21 h test, 15 min bins [n] breaks_XA_mean 55852	inbred w/CC8	8	both	12-13wks	N=17	2018

GMC13:31	GMC13	ECG	(none)	mean SR amplitude, mean amplitude of signal measured from signal minimum line to peak of QRS [mV] SR_amplitude 56231	inbred	6	both	14-15wks	N=15	2018

GMC15:8	GMC15	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 56408	inbred w/CC8	8	both	20-21wks	N=11	2018

GMC15:12	GMC15	complete blood count	(none)	calculated mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 56412	inbred w/CC8	8	both	20-21wks	N=11	2018

GMC16:36	GMC16	metabolic panel	(none)	glucose (plasma GLU) [mmol/L] GLU 56536 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=7	2018

GMC20:4	GMC20	immunoglobulin quantification	(none)	immunoglobulin A (plasma IgA) [µg/mL] IgA 56904 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=5	2018

Hadsell2:2	Hadsell2	mineral quantification	(none)	milk copper (Cu) concentration [µM] copper 110060	inbred	31	f	14-20wks	N=8	2018

Hadsell2:9	Hadsell2	mineral quantification	(none)	milk zinc (Zn) concentration [µM] zinc 110067	inbred	31	f	14-20wks	N=8	2018

HMDPpheno4:61	HMDPpheno4	fear conditioning test	(none)	cued fear, velocity, day 3 [cm/s] vel 46861 pre-cue cue	HMDP w/par	94	m	10wks	N=7	2011

Jax5:4	Jax5	colony observation	(none)	number of pups born per litter [n] born 31404	inbred	35	f	6-40wks	N=184	2009

Jax5:5	Jax5	colony observation	(none)	number of pups weaned per litter [n] wean 31405	inbred	35	f	6-40wks	N=184	2009

Jax5:8	Jax5	colony observation	(none)	mean number of pups born based on mean number of litters per dam [n] born_mean 31408	inbred	35	f	6-40wks	N=46	2009

Jax5:10	Jax5	colony observation	(none)	mean number of pups weaned based on mean number of litters per dam [n] wean_mean 31410	inbred	35	f	6-40wks	N=46	2009

Jaxpheno2:22	Jaxpheno2	organ weights	(none)	liver weight as percentage of body weight [%] pct_liver 22722 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno3:1	Jaxpheno3	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 22801 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:10	Jaxpheno3	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 22810 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:25	Jaxpheno3	metabolic panel	(none)	blood urea nitrogen (BUN) [mg/dL] BUN 22825 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:30	Jaxpheno3	lipid profile	(none)	cholesterol (plasma CHOL) [mg/dL] CHOL 22830 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:40	Jaxpheno3	lipid profile	(none)	triglycerides (plasma, 4h fast) [mg/dL] TG 22840 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxwest1:21	Jaxwest1	grip strength	(none)	grip strength mean peak tension over 5 trials [g] tension_mean 15121	inbred	7	both	9-12wks	N=8	2003

Jaxwest1:22	Jaxwest1	grip strength	(none)	grip strength maximum peak tension over 5 trials [g] tension_max 15122	inbred	7	both	9-12wks	N=8	2003

Johnson1:2	Johnson1	ABR test	(none)	auditory brainstem response (ABR) threshold, 3-12 wk old group, sound pressure level [dB] pip_yng 1402 click 8kHz pip 16kHz pip 32kHz pip	inbred	42	both	3-12wks	N=7	2000

Jones1:20	Jones1	colony observation	(none)	animal age when tested (local parameter) [wks] age 14220	inbred	18	both		N=4	2003

Kliethermes1:11	Kliethermes1	two chamber assay	(none)	activity (beam breaks) in familiar compartment of novelty preference apparatus prior to preference test [n] activity_fam_prior_NP 59911	inbred	14	both	8wks	N=6	2006

Kumar2:1	Kumar2	open field test	(none)	distance traveled, 55 min test [cm] distance 65001 first 10 min total	inbred	58	both	7-26wks	N=16	2019

Kumar3:11	Kumar3	open field test	(none)	distance traveled in first 20 min [cm] OFDistTraveled20m 112919	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:12	Kumar3	open field test	(none)	distance traveled in first 55 min [cm] OFDistTraveled55m 112920	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:15	Kumar3	open field test	(none)	time spent in periphery first 55 min [s] OFPeripheryTime55m 112923	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:18	Kumar3	open field test	(none)	time spent in corners first 55 min [s] OFCornerTime55m 112926	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar4:3	Kumar4	open field test	(none)	distance traveled during approximately one hour test [cm] distance 114433	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:4	Kumar4	gait analysis	(none)	number of strides, hind paws (keypoints) [n] stride_count 114434	inbred w/CC8	62	both	10-20wks	N=19	2021

Loos2:26	Loos2	home cage monitoring	(none)	change in Spout zone duration: anticipation of phase change, over 3 days of testing spout_anticipation 54026 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:28	Loos2	home cage monitoring	(none)	change in Spout zone duration: response to phase onset, over 3 days of testing spout_response 54028 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Moy1:5	Moy1	three chamber assay	(none)	time spent sniffing empty cage (a novel object), 10 min test [s] SnOBJ_soc 30105	inbred	17	m	6-7wks	N=22	2008

Naggert1:2	Naggert1	metabolic panel	high-fat diet	glucose (plasma GLU, 4h fast) [mg/dL] GLU 14302 baseline after 17wks on diet Δchange	inbred w/CC7	43	both	7-9wks	N=10	2003

Odet1:44	Odet1	histopathology	(none)	percentage of sperm with broken tails [%] sperm_broken_tail 53744	inbred w/CC8	8	m	10-66wks	N=14	2015

Paigen1:8	Paigen1	organ dimensions	high-fat diet	gallbladder volume [µL] gbvol 2908	inbred	43	both	15-19wks	N=8	2000

Paigen2:21	Paigen2	lipid profile	high-fat diet	triglycerides (plasma, 4h fast) [mg/dL] TG 9921 baseline after 17wks on diet Δchange	inbred w/CC7	42	both	7-9wks	N=9	2002

Peters1:5	Peters1	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 6205	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:16	Peters1	complete blood count	(none)	basophil differential (percent of total WBC) [%] BASO 6216	inbred w/CC7	43	both	10wks	N=11	2001

Peters1:17	Peters1	complete blood count	(none)	reticulocyte differential (percent of total RBC) [%] Retic 6217	inbred w/CC7	43	both	10wks	N=12	2001

Pletcher1:6	Pletcher1	open field test	(none)	percent of center avoidance, thigmotaxis, 10 min test [%] OFT_thigmotaxis 36006	inbred	31	m	7-10wks*	N=15	2007

Pletcher1:7	Pletcher1	open field test	(none)	total distance traveled, 10 min test [cm] OFT_activity 36007	inbred	31	m	7-10wks*	N=15	2007

Rhodes1:11	Rhodes1	body weight	exercise	change in body weight [ratio] BW_chg 34611 control with running wheel	inbred	12	both	15wks	N=4	2010

Rusyn2:22	Rusyn2	metabolic panel	trichloroethylene	aspartate transaminase (serum AST), control group [IU/L] AST_ctrl 36122 time: 2h 8h 24h	inbred	16	m	7wks	N=3	2010

Rusyn2:41	Rusyn2	organ weights	(none)	liver weight as percent of body weight, naive [ratio (local parameter)] LW_adj 36141	inbred	14	m	7wks	N=3	2010

Rusyn2:44	Rusyn2	organ weights	(none)	liver weight as percent of body weight, t=24h (local parameter) [%] LW_adj24_ctrl 36144	inbred	16	m	7wks	N=3	2010

Rusyn6:68	Rusyn6	RNA expression profiling	trichloroethylene	Acox1, mRNA in kidney, relative to control group [ratio] Acox1_kidney_tce 51268	inbred	7	m	6-7wks	N=3	2014

Rusyn6:70	Rusyn6	RNA expression profiling	trichloroethylene	Cyp4a10, mRNA in kidney, relative to control group [ratio] Cyp4a10_kidney_tce 51270	inbred	7	m	6-7wks	N=3	2014

Rusyn6:72	Rusyn6	RNA expression profiling	trichloroethylene	Ppara, mRNA in kidney, relative to control group [ratio] Ppara_kidney_tce 51272	inbred	7	m	6-7wks	N=3	2014

Seburn1:23	Seburn1	monitoring system	(none)	total activity, beam breaks per min, 3 day test [n/min] tot 9223 daily light dark	inbred	16	both	7-9wks	N=8	2001

Taft1:5	Taft1	assisted reproduction	(none)	percent of live oocytes per donor [%] pct_live_super 19305	inbred	10	f		N=17	2006

Taft1:7	Taft1	assisted reproduction	(none)	percent of fragmented oocytes per donor [%] pct_frag_super 19307	inbred	10	f		N=17	2006

Taft1:13	Taft1	assisted reproduction	(none)	dead embryos, percentage of IVF dish cells [%] pct_dead_IVF 19313	inbred	10	f		N=17	2006

Taft1:14	Taft1	assisted reproduction	(none)	fragmented oocytes, percentage of IVF dish cells [%] pct_frag_IVF 19314	inbred	10	f		N=17	2006

Tarantino1:8	Tarantino1	open field test	cocaine	rearing episodes, 30 min test [n] rear 45921 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino2:16	Tarantino2	open field test	ovariectomy	distance traveled in center of arena, 10 min test [cm] OFT_center_distance 50616 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Threadgill1:14	Threadgill1	metabolite quantification	acetaminophen	reduced glutathione (GSH) [µmol/g] GSH 19414 control post-Rx 300mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Threadgill1:18	Threadgill1	metabolite quantification	acetaminophen	total glutathione (GSH plus GSSG) [µmol/g] GSH_total 19418 control post-Rx 300 mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Wahlsten1:4	Wahlsten1	organ weights	(none)	brain weight, after fixation and trimming [g] brain_wt 10804 weight as percent of body weight	inbred	21	both	12wks	N=10	2003

Wahlsten1:20	Wahlsten1	open field test	(none)	distance traveled in 1 min [cm] dist_OFT 10820 during minute: 1 2 3 4 5	inbred	21	both	9wks	N=9	2003

Wahlsten1:25	Wahlsten1	open field test	(none)	average speed over 5 min trial [cm/sec] speed_ave_OFT 10825	inbred	21	both	9wks	N=9	2003

Wahlsten1:33	Wahlsten1	open field test	(none)	average distance traveled in 1 min [cm] dist_ave_OFT 10833	inbred	21	both	9wks	N=9	2003

Wahlsten1:54	Wahlsten1	elevated plus maze	(none)	time spent in center 5 x 5 cm hub [s] center 10854	inbred	21	both	9wks	N=9	2003

Wahlsten2:10	Wahlsten2	behavior observation	(none)	wildness rating, mean during water escape [score] wmaze 16010	inbred	21	both	10-12wks	N=9	2003

Wahlsten2:11	Wahlsten2	behavior observation	(none)	wildness rating, mean during weighing [score] weigh 16011	inbred	21	both	10-12wks	N=9	2003

Wiltshire3:25	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GAL, relative fluorescence intensity GAL 38125 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:46	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GSK3B, relative fluorescence intensity GSK3B 38146 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:58	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex NPY, relative fluorescence intensity NPY 38158 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:82	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SLC6A4 (SERT), relative fluorescence intensity SLC6A4 38182 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:88	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex TNF (TNFa), relative fluorescence intensity TNF 38188 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire4:1	Wiltshire4	immune cell quantification	BEZ235	B cells, percent viability [%] Bcells_BEZ 52401 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Zimmermann1:9	Zimmermann1	monitoring system	(none)	fine or stationary movement on x-y axis, repeated interruptions of same beam, second day (beam breaks/min) [n/min] fine_act 112172 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:11	Zimmermann1	monitoring system	(none)	ambulatory movement on x-y axis, consecutive interruptions of different beams, second day (beam breaks/min) [n/min] amb_act 112174 during light during dark	inbred	30	both	7-15wks	N=11	2020